Veröffentlichungen A-Z
- 32nd Meeting of the European Regional Commission for Certification of Poliomyelitis Eradication (RCC) Report (2018)
- 6th meeting of the Regional Verification Commission for Measles and Rubella Elimination (RVC)
- Best practice guidance: How to respond to vocal vaccine deniers in public (2017)
- Bestandsaufnahme der Impfstoffpreise: vorgelegt von den Mitgliedstaaten in der Europäischen Region der WHO durch das Gemeinsame Meldeformular von WHO und UNICEF für 2013 (2015)
- Epidemiologisches Bulletin der WHO: Polioausbruch in der Europäischen Region und Gegenmaßnahmen der Länder
- European Vaccine Action Plan midterm report (2018)
- Fact sheet for health workers: Comirnaty® Pfizer/BioNTech BNT162b2 vaccine (international nonproprietary name: tozinameran) (2021) (produced by WHO/Europe)
- Falls Sie sich gegen eine Impfung Ihres Kindes entscheiden, nehmen Sie bitte Risiken und Verantwortung zur Kenntnis
- Grippe: Anzeichen, Symptome & Komplikationen; Empfehlungen zur Vorbeugung
- Impfpräventable Krankheiten: Anzeichen, Symptome & Komplikationen
- Job aid for COVID-19 vaccine administration: Comirnaty® Pfizer/BioNTech BNT162b2 vaccine (international nonproprietary name: tozinameran) (2021) (produced by WHO/Europe)
- Leitlinien für die Enterovirus-Surveillance. Leitlinien für die Surveillance von Enteroviren zur Unterstützung der Weltweiten Initiative zur Ausrottung der Kinderlähmung
- Measles and rubella country profile – Albania (2019)
- Measles and rubella country profile – Andorra (2019)
- Measles and rubella country profile – Armenia (2019)
- Measles and rubella country profile – Austria (2019)
- Measles and rubella country profile – Azerbaijan (2019)
- Measles and rubella country profile – Belarus (2019)
- Measles and rubella country profile – Belgium (2019)
- Measles and rubella country profile – Bosnia and Herzegovina (2019)
- Measles and rubella country profile – Bulgaria (2019)
- Measles and rubella country profile – Croatia (2019)
- Measles and rubella country profile – Cyprus (2019)
- Measles and rubella country profile – Czechia (2019)
- Measles and rubella country profile – Denmark (2019)
- Measles and rubella country profile – Estonia (2019)
- Measles and rubella country profile – Finland (2019)
- Measles and rubella country profile – France (2019)
- Measles and rubella country profile – Georgia (2019)
- Measles and rubella country profile – Germany (2019)
- Measles and rubella country profile – Greece (2019)
- Measles and rubella country profile – Hungary (2019)
- Measles and rubella country profile – Iceland (2019)
- Measles and rubella country profile – Ireland (2019)
- Measles and rubella country profile – Israel (2019)
- Measles and rubella country profile – Italy (2019)
- Measles and rubella country profile – Kazakhstan (2019)
- Measles and rubella country profile – Kyrgyzstan (2019)
- Measles and rubella country profile – Latvia (2019)
- Measles and rubella country profile – Lithuania (2019)
- Measles and rubella country profile – Luxembourg (2019)
- Measles and rubella country profile – Malta (2019)
- Measles and rubella country profile – Monaco (2019)
- Measles and rubella country profile – Montenegro (2019)
- Measles and rubella country profile – Netherlands (2019)
- Measles and rubella country profile – North Macedonia (2019)
- Measles and rubella country profile – Norway (2019)
- Measles and rubella country profile – Poland (2019)
- Measles and rubella country profile – Portugal (2019)
- Measles and rubella country profile – Republic of Moldova (2019)
- Measles and rubella country profile – Romania (2019)
- Measles and rubella country profile – Russian Federation (2019)
- Measles and rubella country profile – San Marino (2019)
- Measles and rubella country profile – Serbia (2019)
- Measles and rubella country profile – Slovakia (2019)
- Measles and rubella country profile – Slovenia (2019)
- Measles and rubella country profile – Spain (2019)
- Measles and rubella country profile – Sweden (2019)
- Measles and rubella country profile – Switzerland (2019)
- Measles and rubella country profile – Tajikistan (2019)
- Measles and rubella country profile – Turkey (2019)
- Measles and rubella country profile – Turkmenistan (2019)
- Measles and rubella country profile – Ukraine (2019)
- Measles and rubella country profile – United Kingdom of Great Britain and Northern Ireland (2019)
- Measles and rubella country profile – Uzbekistan (2019)
- Measles and rubella elimination 2015. Package for accelerated action: 2013-2015
- Mit Eltern über Impfstoffe für Kinder sprechen
- Narrativer Bericht: Europäische Impfwoche 2013
- Sichtung der Evidenz in Bezug auf eine ausgewogene Bereitstellung, Zugänglichkeit und Inanspruchnahme von Impfangeboten für Migranten und Flüchtlinge in der Europäischen Region der WHO (Eine) (2017)
- Vierte Tagung der Verifizierungskommission der Europäischen Region für die Eliminierung der Masern und Röteln, 26.–29. Oktober 2015
- WHO EpiBrief, No. 1/2019
- WHO EpiBrief, No. 1/2020
- WHO EpiBrief, No. 1/2021
- WHO EpiBrief, No. 2/2018
- WHO EpiBrief, No. 2/2019
- WHO EpiBrief, No. 2/2020
- WHO EpiData, 1/2018
- WHO EpiData, 1/2018
- WHO EpiData, 3/2018 – Neueste Daten zu Masern und Röteln in der Europäischen Region der WHO
- WHO EpiData, April 2017 - March 2018
- WHO EpiData, April 2017 - March 2018
- WHO Epidata, December 2017 - November 2018
- WHO Epidata, December 2017 - November 2018
- WHO Epidata, December 2017 - November 2018
- WHO Epidata, December 2017 - November 2018
- WHO Epidata, December 2017 - November 2018
- WHO Epidata, December 2017 - November 2018
- WHO Epidata, December 2017 - November 2018
- WHO EpiData, No. 8/2019, August 2018—July 2019
- WHO EpiData, No. 8/2019, August 2018—July 2019
- WHO EpiData, No. 8/2019, August 2018—July 2019
- WHO EpiData, No. 8/2019, August 2018—July 2019
- WHO EpiData, No. 8/2019, August 2018—July 2019
- Zielgenaue Ausrichtung von Impfprogrammen (TIP) (2019)
- Zielgenaue Ausrichtung von Impfprogrammen gegen saisonale Influenza (TIP FLU). Untersuchung der Akzeptanz von Impfungen gegen saisonale Grippe bei Gesundheitspersonal in Montenegro: eine Fallstudie für politische Entscheidungsträger und Leiter von Impfprogrammen
